Chapter 23: Q15P (page 829)
Is trimethoprim a mechanism-based inhibitor of bacterial dihydrofolate reductase?
Short Answer
Trimethoprim is not a mechanism-based inhibitor of bacterial DHFR because it is a reversible inhibitor.
/*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none}
Learning Materials
Features
Discover
Chapter 23: Q15P (page 829)
Is trimethoprim a mechanism-based inhibitor of bacterial dihydrofolate reductase?
Trimethoprim is not a mechanism-based inhibitor of bacterial DHFR because it is a reversible inhibitor.
All the tools & learning materials you need for study success - in one app.
Get started for free
List the starting materials and cofactors required for IMP biosynthesis.
Why is gout more prevalent in populations that eat relatively large amounts of meat?
Some microorganisms lack DHFR activity, but their thymidylate synthase has an FAD cofactor. What is the function of the FAD?
Describe how free purines are converted back to nucleotides.
What are the physiological implications of excreting waste nitrogen in the form of urate, urea, or ammonia?
What do you think about this solution?
We value your feedback to improve our textbook solutions.